Aytu Biopharma AYTU Balance Sheet (2011-2026)

NASDAQ AYTU
$2.16 -0.03 (-1.37%)
As of: Sep 9, 2026 · 1:25 PM EDT
Reported Financials

Aytu Biopharma Quarterly Balance Sheet

Periods 58 quarters
Latest Mar 2026

Aytu Biopharma reported total assets of $111.69M and total liabilities of $76.55M for the quarter ended Mar 2026, down 10.1% year over year. This balance sheet covers 58 quarters of results from Aug 2011 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Feb2014 May2014 Sep2014 Dec2014 Feb2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
49.90M40.31M35.28M27.61M19.36M23.81M19.50M19.18M22.98M19.96M19.53M19.76M20.01M20.11M20.40M18.17M30.95M32.63M30.02M26.71M
Short-term InvestmentsInvestments (Current)
0.25M0.25M
Cash & Current Investments
50.15M40.56M35.28M27.61M19.36M23.81M19.50M19.18M22.98M19.96M19.53M19.76M20.01M20.11M20.40M18.17M30.95M32.63M30.02M26.71M
Receivables - NetNet Receivables
30.32M21.63M22.99M27.61M24.22M27.92M25.55M34.04M31.72M29.90M29.40M29.93M25.35M23.16M25.40M35.83M31.16M33.23M30.92M24.49M
Receivables - OtherOther Receivables
0.02M0.01M6.20M5.80M5.80M4.30M3.10M
Receivables
30.35M21.64M22.99M27.61M24.22M27.92M25.55M34.04M31.72M29.90M29.40M29.93M31.55M28.96M31.20M40.12M34.26M33.23M30.92M24.49M
Raw Materials
2.27M2.64M2.43M1.80M1.81M2.11M1.79M2.22M1.30M1.97M1.65M1.85M0.27M0.72M0.49M0.54M1.11M1.37M1.21M1.37M
Work In Process
3.35M3.01M2.17M2.22M1.84M2.37M2.80M2.82M2.96M3.29M2.67M5.02M5.72M3.36M3.10M2.06M1.38M0.86M1.82M2.05M
Finished Goods
10.72M10.67M11.96M9.87M7.20M8.38M8.36M8.60M7.74M7.71M8.67M6.32M6.15M7.66M7.49M8.46M8.94M7.87M5.63M4.04M
Inventory
16.34M16.31M16.56M13.89M10.85M12.87M12.95M13.64M11.99M12.97M13.00M13.19M12.14M11.74M11.09M11.06M11.43M10.10M8.66M7.46M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
9.78M9.34M11.30M7.94M7.38M9.02M11.99M10.43M71.08M7.04M8.11M7.25M5.10M60.74M63.05M7.46M5.64M5.15M6.64M8.66M
Current Assets
105.23M89.04M87.54M77.95M59.93M74.42M70.61M78.47M72.83M70.60M71.37M71.13M61.89M60.74M63.05M72.51M79.18M81.11M76.24M67.33M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
5.14M4.67M4.29M3.48M3.02M2.67M2.34M2.03M1.81M1.72M1.13M0.97M0.69M0.69M0.52M0.55M0.53M0.50M0.48M0.41M
Goodwill
65.80M46.35M46.35M8.64M
Intangibles
94.22M94.22M94.22M94.22M94.22M89.55M89.55M89.55M78.58M78.58M77.87M77.87M71.47M71.47M71.47M71.47M55.40M55.40M58.40M58.40M
Goodwill & Intangibles
160.02M140.57M140.57M102.86M94.22M89.55M89.55M89.55M78.58M78.58M77.87M77.87M71.47M71.47M71.47M71.47M55.40M55.40M58.40M58.40M
Long-Term Deferred Tax
0.10M
Other Non-Current Assets
0.47M0.47M0.46M0.77M0.77M0.83M0.82M0.89M2.54M0.77M0.91M0.89M2.19M1.97M1.52M1.32M1.20M0.94M0.74M0.56M
Non-Current Assets
160.43M138.69M136.28M90.88M77.69M75.58M70.83M68.75M65.38M62.29M59.88M57.73M56.20M55.09M53.17M51.69M45.00M43.88M45.76M44.36M
Assets
265.67M227.73M223.82M168.83M137.62M150.00M141.44M147.22M136.46M132.89M131.25M128.86M118.09M115.83M116.23M124.20M124.18M124.99M122.00M111.69M
Liabilities
Current Liabilities
Accounts Payables
19.25M13.48M10.47M10.47M10.31M13.51M11.70M12.04M10.60M12.34M14.26M13.21M
Notes Payables
3.81M7.43M10.40M1.56M1.22M1.03M3.26M2.40M4.27M4.01M
Payables
19.25M3.81M7.43M10.40M15.04M1.22M11.50M13.74M12.71M17.78M15.71M12.04M10.60M12.34M14.26M13.21M
Accumulated Expenses
57.23M54.38M50.69M53.47M44.19M41.43M41.22M49.59M46.80M40.73M43.41M44.09M38.14M33.72M39.37M41.73M38.16M36.70M40.16M34.27M
Other Accumulated Expenses
8.35M3.19M3.17M3.54M5.36M8.09M7.83M7.45M7.09M8.99M9.24M9.15M8.96M7.89M7.11M5.05M3.38M1.97M2.92M2.20M
Short term Debt
16.67M16.51M16.34M3.38M3.81M8.09M7.43M10.40M1.56M1.22M1.03M15.13M2.40M4.27M4.01M10.03M9.06M14.87M9.07M10.41M
Current Leases
0.94M1.08M1.17M1.20M
Current Taxes
Current Deferred Revenue
Total Current Liabilities
109.44M98.00M100.57M80.36M64.44M73.20M67.15M85.42M69.02M65.46M64.19M83.69M62.23M61.25M64.05M70.71M63.06M65.99M65.56M59.97M
Non-Current Liabilities
Non-Current Debt
0.18M0.15M0.13M15.00M14.28M15.00M15.00M15.00M14.71M15.00M14.98M10.88M10.43M9.98M9.54M10.89M10.45M10.00M9.55M
Convertible Debt
Non-Current Deffered Revenue
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
0.56M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
0.20M0.10M0.10M0.10M0.10M
Operating Leases
2.62M2.76M2.72M2.41M
Other Non-Current Liabilities
18.48M8.17M8.30M5.58M12.80M9.33M9.78M7.92M6.97M12.31M12.89M8.61M12.74M9.40M6.39M4.94M26.33M20.42M27.34M4.84M
Total Non-Current Liabilities
109.62M108.06M109.99M102.11M80.52M92.32M85.84M98.38M28.09M88.41M34.21M14.40M28.15M24.75M21.41M18.60M42.15M35.82M42.24M16.57M
Total Liabilities
128.10M116.23M118.29M107.68M93.31M101.65M95.62M106.30M97.11M100.72M-68.75M98.09M90.38M86.00M85.46M89.30M105.21M101.82M107.80M76.55M
Shareholder's Equity
Total Debt
16.85M16.66M16.47M18.39M21.91M23.09M29.86M35.81M17.84M17.43M17.03M18.40M15.67M18.97M18.01M19.56M19.96M25.32M19.07M19.96M
Common Equity
137.57M111.50M105.54M61.14M44.31M48.35M45.82M40.91M39.36M32.17M200.00M30.78M27.72M29.83M30.77M34.90M18.97M23.17M14.20M35.14M
Liabilities and Shareholders Equity
265.67M227.73M223.82M168.83M137.62M150.00M141.44M147.22M136.46M132.89M131.25M128.86M118.09M115.83M116.23M124.20M124.18M124.99M122.00M111.69M
Retained Earnings
-178.30M-206.20M-217.70M-270.80M-287.10M-287.80M-294.50M-301.70M343.49M-312.25M345.32M346.13M347.69M348.32M348.48M348.61M352.50M354.74M356.35M382.91M
Preferred Shares
50.00M